DLC1 is a tumor suppressor in many different cancer types, including in lung cancer [36, 37] and could inhibit cancer cells through Rho GTPase accelerating proteins (GAP) dependent- and independent-mechanisms [38]. The gene discussed is DLC1; the disease is neoplasm.